Company Overview

Update
Founded:
1988
Headquarters:
Ontario Center
Funding:
$2.10M
Categories:
Biotechnology

Microbix Biosystems develops biological products and technologies primarily for the diagnostics market.

Description

Update

Watline Avenue | Microbix Biosystems Inc. Microbix Biosystems Inc. develops biological products and technologies. The Company was founded in 1988 as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies including VIRUSMAX (Influenza Virus Yield Enhancement Technology), LumiSort™ (Semen Sexing Technology) and the thrombolytic drug, Kinlytic® (Urokinase). Funded by income from the antigen business, the pipeline products take aim at large market opportunities. With Microbix’ core competencies in the Infectious Disease Antigen business, including cell culture, molecular biology,... See More

Current Team (1)

Update

Funding Rounds (4) - $2.10M

Update

Offices/Locations (1)

Update
  • Office

    265 Watline Avenue

    Mississauga

    Ontario Center, L4Z 1P3

    CAN

Images (1)

Update
  • Cd3a715e1f1d57c48119837839aa7131